Local nifedipine market seen intensifying
Published: 2004-01-26 07:00:00
Updated: 2004-01-26 07:00:00
The domestic nifedipine market is expected to intensify this year, as some Korean companies such as Hanmi Pharm and Pacific Pharm plan to launch new formulations within the year in the hope of carving out bigger market share.
So far, Bayer's Adalat Oros has led the domestic antihypertensive ma...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
